Please login to the form below

Not currently logged in

BMS’ Brian Daniels to retire

He will step down from role as senior VP, global development and medical affairs
BMS Brian Daniels

Dr Brian Daniels is to retire from his role as senior VP, global development and medical affairs at Bristol-Myers Squibb (BMS) on July 1, 2014.

Dr Daniels has been with BMS since 2000 as VP of the immunology, pulmonary, and dermatology therapeutic area where he worked on such compounds as rheumatoid arthritis drug Orencia (abatacept). He took on his current role in 2008.

Francis Cuss, executive vice president and chief scientific officer, BMS said: "He has been a champion of the patients we serve, and I want to sincerely thank him for his loyalty and dedication to Bristol-Myers Squibb."

Prior to joining BMS, Dr Daniels spent four years at Merck Research Laboratories in clinical research where he ultimately assumed the role of senior director, pulmonary and immunology. He has also worked in clinical research at Genentech.

7th May 2014


Featured jobs

Subscribe to our email news alerts


Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

When is it time to rebrand?
The Biosimilar Challenge
How health behaviours and clinical outcomes are related
When HCPs understand patient activation levels they can actively guide patients towards more confident self-management of diverse health concerns....